TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04719039

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Restorative Yoga Internvention
Description: Participants in the intervention group will receive links to two 60-min videos per week for 8 consecutive weeks. Each video will include a yoga practice guided by a certified yoga instructor. The intervention group is required to perform the yoga practice at least two times per week. If preferred, they can do additional sessions with the videos and record their total hours of self-practice.
Study: NCT05581680

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: dental impressions
Description: dental impressions

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: dental impressions
Description: dental impressions

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Simultaneous MoCap and EMG acquisition
Description: Simultaneous MoCap and EMG acquisition

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simultaneous MoCap and EMG acquisition
Description: Simultaneous MoCap and EMG acquisition

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Eye-tracking acquisition for pathological subjects
Description: Eye-tracking acquisition for pathological subjects

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Follow-up visit for pathological subjects
Description: Follow-up visit for pathological subjects
Study: NCT06052345

Intervention type: OTHER
Intervention: REBECCA PC plug-in
Description: * the developed plug-in monitors online activity, collecting anonymized data from web-browsers (Chrome) and social media (Facebook, Youtube and Instagram).~* These are relevant to current and historical data on: i) keywords in searches, ii) types of websites visited, iii) reactions to posts, iv) participation in online groups, v) types of bookmarked websites
Study: NCT04595097

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: inspiratory muscle traiing
Description: The patients are encouraged to inhale against a load to increase the inspiratory muscle strength and endurance

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: inspiratory muscle traiing
Description: The patients are encouraged to inhale against a load to increase the inspiratory muscle strength and endurance
Study: NCT05065164

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Denosumab Only Product
Description: denosumab subcutaneous injection /6 months, twice a year

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Denosumab Only Product
Description: denosumab subcutaneous injection /6 months, twice a year
Study: NCT06491654

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 12-week supervised exercise
Description: During the study period (1 week for acute effects, 12 weeks for chronic effects), there will be 8 sessions per month, lasting 40-60 minutes each, with 2 sessions per week on alternate days, totaling 24 sessions. Each session includes: (1) warm-up (mobility exercises); (2) training: 5-min warm-up, followed by 15-min moderate-to-high intensity circuit of 7 functional global exercises with 10 reps each at a perceived exertion effort (RPE) of 5-7 on a scale of 1 to 10; (3) Aerobic exercise: starting at 15 mins, increasing by 5 mins biweekly to 30 mins by week 7; (4) Cool-down (general mobility); (5) Application of cohesive compressive bandage on the affected upper limb, worn for 2 hours post-session, removed at home. Participants may add a cotton bandage and finger bandage if needed.
Study: NCT05108298

Intervention type: OTHER
Group type: OTHER
Intervention: Questionnaires
Description: Patients will complete questionnaires online through EASEE-PRO. There will be a set of fixed questionnaires at each timepoint for both arms. The patients will be asked to rank the 15 types of PROs according to their importance. The participants randomized to the choice arm will be asked to choose 5 of the 15 PROs to complete. The participants randomized to the fixed arm will be given a fixed 5 of the 15 PROs at each time point.
Study: NCT05375383

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Streptococcus salivarius K12 lozenge
Description: In this study, a lozenge will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic S. salivarius K12 lozenges containing prebiotic A
Description: In this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.
Study: NCT05108298

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: Patients will complete questionnaires online through EASEE-PRO. There will be a set of fixed questionnaires at each timepoint for both arms. The patients will be asked to rank the 15 types of PROs according to their importance. The participants randomized to the choice arm will be asked to choose 5 of the 15 PROs to complete. The participants randomized to the fixed arm will be given a fixed 5 of the 15 PROs at each time point.
Study: NCT05375383

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic S. salivarius K12 lozenges containing prebiotic B
Description: In this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic S. salivarius K12 lozenges containing prebiotics A and B
Description: In this study, a lozenge containing two prebiotics will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity.
Study: NCT05993702

Intervention type: DRUG
Intervention: regorafenib
Description: (TAS102): Trifluridine tepipiridine tablets 35 mg/m2 twice a day, D1-5, D15-D19, 28 days as a cycle; (TKI: regorafenib: regorafenib capsules administered at a dose of 80 mg (2 tablets, each containing 40 mg regorafenib) once daily for a 28-day cycle)

Intervention type: DRUG
Intervention: fruquintinib
Description: TAS102: Trifluridine tepipiridine tablets 35 mg/m2 twice a day, D1-5, D15-D19, 28 days as a cycle; or Fruquintinib: a dose of 3mg/dose administered orally once daily, continuously for 28 days as a cycle.
Study: NCT04810221

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Controlled desaturation study
Description: Measure of SpO2 and Heart Rate by BrOxy M device and reference device in a controlled desaturation study.
Study: NCT05375383

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic S. salivarius K12 powder
Description: In this study, a powder will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic S. salivarius K12 powder containing prebiotic A
Description: In this study, a powder containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity
Study: NCT06264557

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SB-100
Description: Cognitive training will be conducted once a day, and it will take 15 to 30 minutes.~It consists of cognitive training and educational videos.

Intervention type: OTHER
Group type: OTHER
Intervention: Educational book
Description: Book of education on daily rules for preventing dementia
Study: NCT05631093

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ART
Description: Standard of care ART, per approved product list, taken orally

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DOR/ISL
Description: Combination of 100 mg doravirine (DOR) with 0.25 mg Islatravir (ISL) in tablet form, taken orally, once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DOR/ISL
Description: Combination of 100 mg doravirine (DOR) with 0.25 mg Islatravir (ISL) in tablet form, taken orally, once daily.
Study: NCT05027906

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AT-1501
Description: Investigative Arm
Study: NCT04959929

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Focal vibration therapy
Description: Myovolt is a wearable rehabilitative device that delivers vibration to the region of the body where the motors are worn. Participants are asked to apply the vibration to specific leg locations twice a day, for about 30 minutes at a time, and to record their response using a provided log. They may be asked to try applying the device at different location or using different vibration parameters (pulse frequency or intensity).
Study: NCT05375383

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic S. salivarius K12 powder containing prebiotic B
Description: In this study, a powder containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity
Study: NCT06193278

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Neuromodulation
Description: Noninvasive brain stimulation (NIBS) includes a variety of noninvasive neuromodulation techniques such as transcranial magnetic stimulation (TMS), transcranial direct current stimulation (TDCS), and so on. Theta burst stimulation(TBS) is a new form of excitatory or inhibitory rTMS treatment that is less time-consuming and more effective than traditional rTMS in a single treatment session.
Study: NCT05497713

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindsets
Description: The primary objective of this trial is to determine whether mindsets sustain the feasibility of taking cold showers over a 3-month period.
Study: NCT06193278

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Neuromodulation
Description: Noninvasive brain stimulation (NIBS) includes a variety of noninvasive neuromodulation techniques such as transcranial magnetic stimulation (TMS), transcranial direct current stimulation (TDCS), and so on. Theta burst stimulation(TBS) is a new form of excitatory or inhibitory rTMS treatment that is less time-consuming and more effective than traditional rTMS in a single treatment session.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Neuromodulation
Description: Noninvasive brain stimulation (NIBS) includes a variety of noninvasive neuromodulation techniques such as transcranial magnetic stimulation (TMS), transcranial direct current stimulation (TDCS), and so on. Theta burst stimulation(TBS) is a new form of excitatory or inhibitory rTMS treatment that is less time-consuming and more effective than traditional rTMS in a single treatment session.
Study: NCT04806009

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 'Mindful Living With Insomnia (MLWI)' Intervention via WeChat mini-program
Description: The MLWI Intervention involves 12 sessions over 6 weeks course, 2 sessions a week and 0.5 hours per session. Two new sessions of online lessons will be updated weekly in the 6 weeks. Each session is consisted of theoretical lecture, mindfulness practices, sharing common difficulties and coping way during mindfulness practices and homework assignment in the form of video or audio. The Mindfulness practices embedded in the intervention include mindful breathing, mindful body scan, mindful dealing with thoughts and emotions, mindful meditation, mindful movement, and daily life mindfulness. In the intervention, the participants will also receive sleep hygiene education.Participants in the Intervention Group will receive the MLWI Intervention after follow the WeChat mini-program.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: 'Cognitive Behavioral Therapy for insomnia (CBT-I)'via WeChat mini-program
Description: The CBT-I involves 12 sessions over 6 weeks course, 2 sessions a week and 0.5 hours per session. Two new sessions of online lessons will be updated weekly in the 6 weeks. Each session is consisted of theoretical lecture, cognitive or behavioral regulation techniques, sharing common difficulties and coping way during mindfulness practices and homework assignment in the form of video or audio.Participants in the Control Group will receive CBT-I after follow the WeChat mini-program.
Study: NCT05497713

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindsets
Description: The primary objective of this trial is to determine whether mindsets sustain the feasibility of taking cold showers over a 3-month period.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindsets
Description: The primary objective of this trial is to determine whether mindsets sustain the feasibility of taking cold showers over a 3-month period.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindsets
Description: The primary objective of this trial is to determine whether mindsets sustain the feasibility of taking cold showers over a 3-month period.
Study: NCT05644223

Intervention type: DRUG
Intervention: edaravone dexborneol
Description: intravenous edaravone dexborneol 37.5mg twice daily
Study: NCT04490720

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: consume 1 sachet per day for 2 months

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Buckwheat husk extract
Description: consume 1 sachet per day for 2 months
Study: NCT05438043

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daratumumab
Description: Daratumumab will be administered either intravenously or subcutaneously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Carfilzomib will be administered intravenously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone will be administered either orally or intravenously.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Lenalidomide will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: Pomalidomide will be administered orally.
Study: NCT04963374

Intervention type: OTHER
Intervention: risk evolution scale
Description: Padua score、Caprini score、Prime score
Study: NCT04582266

Intervention type: DRUG
Intervention: Remdesivir
Description: RDV was not provided as part of the study. Participants were administered RDV intravenously once daily for up to 10 days per clinical care.

Intervention type: DRUG
Intervention: Remdesivir
Description: RDV was not provided as part of the study. Participants were administered RDV intravenously once daily for up to 10 days per clinical care.
Study: NCT06177652

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Paravertebral Block
Description: Ultrasound (US) -guided paravertebral block (PVB) with 20 ml 0.5 % bupivacaine will performe preoperatively to all patients in the PVB group.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Serratus Plane Block
Description: Ultrasound (US) -guided serratus plane block (SPB) with 20 ml 0.5 % bupivacaine will performe preoperatively to all patients in the SPB group.
Study: NCT05426486

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARX788
Description: HER2 antibody-drug conjugate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrotinib maleate
Description: EGFR/HER2 dual inhibitor

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Trastuzumab
Description: anti-Her2 monoclonal antibody

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pertuzumab
Description: anti-HER2 monoclonal antibody

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Docetaxel
Description: Cytotoxic chemotherapy

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Cytotoxic chemotherapy
Study: NCT06136598

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Opevesostat
Description: Tablets to be taken orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Tablets to be taken orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludrocortisone
Description: Tablets to be taken orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Description: Tablet to be taken orally as a rescue medication.
Study: NCT05375383

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic S. salivarius K12 powder containing prebiotics A and B
Description: In this study, a powder containing two prebiotics will be evaluated for its potential of delivering probiotic Streptococcus salivarius K12 to the oral cavity

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic S. salivarius M18 lozenges
Description: In this study, a lozenge containing will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic S. salivarius M18 lozenges containing prebiotic A
Description: In this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic S. salivarius M18 lozenges containing prebiotic B
Description: In this study, a lozenge containing a prebiotic will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic S. salivarius M18 + lozenges containing prebiotic A and B
Description: In this study, a lozenge containing two prebiotics will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.
Study: NCT06423859

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Articaine
Description: supraclavicular brachial plexus block with articaine 2%

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Articaine
Description: supraclavicular brachial plexus block with articaine 2%

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: supraclavicular brachial plexus block with articaine 2% in addition with Dexmedetomidine
Study: NCT05915832

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Remote ischemic conditioning
Description: Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 200 mm Hg.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Sham remote ischemic conditioning
Description: Remote ischemic conditioning (RIC) is induced by 4 cycles of 5 min of healthy upper limb ischemia followed by 5 min reperfusion. Limb ischemia was induced by inflation of a blood pressure cuff to 60 mm Hg.
Study: NCT05875779

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer-led vaccine education intervention
Description: The intervention will be delivered face-to-face by a trained peer-educator and will consist of one session of 10-20 minutes.~Peer vaccine educators will receive written vaccine materials for distribution. These materials will present content that accurately represents the risks and benefits of vaccination.~Responsibilities of the vaccine educators will be to: provide motivational interviewing with patients, provide vaccine counseling, address questions and concerns regarding available vaccines, brief clinical provider on hesitant patients and areas of their vaccine-related concerns, and provide follow-up with participants at day 30, day 60 and day 90 for additional engagement.
Study: NCT05909878

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: The pre-procedural IVR game preparation (IMAGINE) was developed by Paperplane Therapeutics® (intervention development team). IMAGINE is an immersive virtual reality simulation aiming to reduce the anxiety and phobic reactions of young patients and to better prepare them for this exam. Since the game is a preparation, it is a no success game and is independent of the ability and previous experience of the child with video games. It offers an immersive and fun simulation that aims to desensitize young patients to MRI and transform an anxiety-inducing experience into a fun play session. The participant will learn about the main principles of magnetic resonance imaging and experience a very realistic simulation of the MRI exam. This will allow children to prepare for the MRI scanner by enabling them to experience the process of undergoing an MRI exam beforehand.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Protocol
Description: The usual care group will only receive the standard preparation, which comprises of an explanation of the MRI procedure given by the radiology technician as per the radiology department's protocol. Specifically at the hospital (HSJ), standard care also includes access to a television mounted near the MRI playing videos.The research nurse will be able to complete any information should they find it incomplete or substandard.
Study: NCT05921305

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MTX
Description: MTX (5mg/m\^2/day) was given on days 1, 3, and 8, and repeated weekly until aGVHD was CR

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Corticosteroid
Description: Corticosteroid Methylprednisolone 2 mg/kg/day was given for 3 days, and for responding patients, the dose of prednisone must be at least 0.25mg/kg/day prednisone (or 0.2mg/kg/day methylprednisolone).
Study: NCT06569875

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iCARE
Description: iCARE is an internet-based cognitive behavioral therapy program designed for women experiencing symptoms of postpartum depression, including anxiety, irritability, and sadness. The program offers digital therapy through an online platform tailored to mothers with mild to moderate postpartum depression. The program consists of 7 modules, each with its own theme, incorporating cognitive behavioral therapy, a well-established therapeutic approach for depression. The content includes text, images, audio files, and short films, supplemented with small tasks to provide knowledge and tools to understand and manage one's situation. The treatment course is self-directed, allowing participants to engage with the content at their own pace and at times that are most convenient for them
Study: NCT06343311

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: EB103
Description: EB103 is an autologous T-cell therapy whereby a subject's own T cells are transduced with a lentiviral vector expressing the EB103 transgene.
Study: NCT06019689

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CAMI
Description: Culturally Adapted manual-assisted problem solving training based Mobile Intervention (CAMI) for Suicidal Ideation. CMAP is a manual-assisted intervention which has been adapted from a self-help guide called Life After Self-Harm based on the principles of Cognitive behavioral therapy (CBT). This intervention is an evaluation of suicidal ideation, crisis skills, problem-solving and CBT techniques to manage emotions, negative thinking, interpersonal relationships and relapse prevention strategies.